The Effect of Voclosporin as Monotherapy in Treating Lupus Nephritis (KIDNEY WEEK 2023) - Oct 15, 2023 - Abstract #TH-PO656; Pres time: Nov 2, 2023; 10:00 AM - 12:00 PM; Location: Exhibit Hall, Pennsylvania Convention Center; "Introduction: The current standard of care for lupus nephritis typically involves the use of combination therapy with immunosuppressive medications, such as mycophenolate mofetil (MMF) or cyclophosphamide, along with low-dose corticosteroids...The patient was initially treated with a combination of mycophenolate mofetil (MMF), low-dose corticosteroids and hydroxychloroquine...It has been shown to be effective and well-tolerated in combination with MMF and low-dose corticosteroids in the AURA-LV and Aurora 1 trials. This case report demonstrates that voclosporin monotherapy may be an effective and safe treatment option for LN along with low-dose prednisone for LN in patients who are unable to tolerate or have contraindications to other immunosuppressive medications."
Monotherapy • Glomerulonephritis • Hematological Disorders • Immunology • Infectious Disease • Inflammatory Arthritis • Leukopenia • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
|